FDA Fine-Tunes Informed Consent Rules
The U.S. Food and Drug Administration on Tuesday released guidance fine-tuning its expectations for obtaining informed consent from participants in clinical trials, the first update since 1998....To view the full article, register now.
Already a subscriber? Click here to view full article